A detailed history of Park Avenue Securities LLC transactions in Natera, Inc. stock. As of the latest transaction made, Park Avenue Securities LLC holds 7,833 shares of NTRA stock, worth $992,989. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,833
Previous 6,828 14.72%
Holding current value
$992,989
Previous $739,000 34.51%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$97.75 - $129.67 $98,238 - $130,318
1,005 Added 14.72%
7,833 $994,000
Q2 2024

Jul 09, 2024

BUY
$85.28 - $112.6 $124,508 - $164,396
1,460 Added 27.2%
6,828 $739,000
Q1 2024

Apr 10, 2024

BUY
$59.21 - $92.9 $47,308 - $74,227
799 Added 17.49%
5,368 $491,000
Q4 2023

Jan 10, 2024

BUY
$37.55 - $62.64 $171,565 - $286,202
4,569 New
4,569 $286,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $12.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Park Avenue Securities LLC Portfolio

Follow Park Avenue Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.